A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer
Clinical trial NCT00816686 · TERMINATED
Trial details
- NCT number
- NCT00816686
- Sponsor
- Astellas Pharma Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2010-04-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.